Novel 2-phenyl-4H-chromen derivatives: synthesis and anti-inflammatory activity evaluation in vitro and in vivo

References

• Rakariyatham K, Wu X, Tang Z, Han Y, Wang Q, Xiao H. Synergism between luteolin and sulforaphane in anti-inflammation. Food Funct. 2018;79(10):5115–5123.
   PubMed Web of Science ®Google Scholar
• Hu TY, Ju JM, Mo LH, Ma L, Hu WH, You RR, Chen XQ, Chen YY, Liu ZQ, Qiu SQ, Fan JT, et al. Anti-inflammation action of xanthones from Swertia chirayita by regulating COX-2/NF-κB/MAPKs/Akt signalling pathways in RAW 264.7 macrophage cells. Phytomedicine. 2019;55:214–221.
   PubMed Web of Science ®Google Scholar
• Su CM, Hou GG, Wang CH, Zhang HQ, Yang C, Liu M, Hou Y. Potential multifunctional agents with anti-hepatoma and anti-inflammation properties by inhibiting NF-кB activation. J Enzyme Inhib Med Chem. 2019;34(1):1287–1297.
   PubMed Web of Science ®Google Scholar
• Li L, Zhao X, Lu Y, Huang W, Wen W. Altered expression of pro- and anti-inflammatory cytokines is associated with reduced cardiac function in rats following coronary microembolization. Mol Cell Biochem. 2010;342(1–2):183–190.
   PubMed Web of Science ®Google Scholar
• Lv S, Han M, Yi R, Kwon S, Dai C, Wang R. Anti-TNF-α therapy for patients with sepsis: a systematic meta-analysis. Int J Clin Pract. 2014;68(4):520–528.
   PubMed Web of Science ®Google Scholar
• Ciesielska A, Matyjek M, Kwiatkowska K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci. 2021;78(4):1233–1261.
   PubMed Web of Science ®Google Scholar
• Saiki P, Nakajima Y, Van Griensven LJLD, Miyazaki K. Real-time monitoring of IL-6 and IL-10 reporter expression for anti-inflammation activity in live RAW 264.7 cells. Biochem Biophys Res Commun. 2018;505(3):885–890.
   PubMed Web of Science ®Google Scholar
• Facchini FA, Zaffaroni L, Minotti A, Rapisarda S, Calabrese V, Forcella M, Fusi P, Airoldi C, Ciaramelli C, Billod JM, et al. Structure-activity relationship in monosaccharide-based toll-like receptor 4 (TLR4) antagonists. J Med Chem. 2018;61(7):2895–2909.
   PubMed Web of Science ®Google Scholar
• Shi M, Zeng X, Guo F, Huang R, Feng Y, Ma L, Zhou L, Fu P. Anti-inflammatory pyranochalcone derivative attenuates LPS-induced acute kidney injury via inhibiting TLR4/NF-κB pathway. Molecules. 2017;22(10):1683.
   PubMed Web of Science ®Google Scholar
• Chimenti C, Verardo R, Scopelliti F, Grande C, Petrosillo N, Piselli P, De Paulis R, Frustaci A. Myocardial expression of toll-like receptor 4 predicts the response to immunosuppressive therapy in patients with virus-negative chronic inflammatory cardiomyopathy. Eur J Heart Fail. 2017;19(7):915–925.
   PubMed Web of Science ®Google Scholar
• Meanwell NA. Synopsis of some recent tactical application of bioisosteres in drug design. J Med Chem. 2011;54(8):2529–2591.
   PubMed Web of Science ®Google Scholar
• Yao X, Huang J, Zhong H, Shen N, Faggioni R, Fung M, Yao Y. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther. 2014;141(2):125–139.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444.
   PubMed Web of Science ®Google Scholar
• Graham DB, Xavier RJ. Pathway paradigms revealed from the genetics of inflammatory bowel disease. Nature. 2020;578(7796):527–539.
   PubMed Web of Science ®Google Scholar
• Yan Y, Xing C, Xiao Y, Shen X, Zhang Z, He C, Shi JB, Liu M, Liu X. Discovery and anti-inflammatory activity evaluation of a novel CDK8 inhibitor through upregulation of IL-10 for the treatment of inflammatory bowel disease in vivo. J Med Chem. 2022;65(10):7334–7362.
   PubMed Web of Science ®Google Scholar
• Chen LZ, Zhang XX, Liu MM, Wu J, Ma D, Diao LZ, Li Q, Huang YS, Zhang R, Ruan BF, et al. Discovery of novel pterostilbene-based derivatives as potent and orally active NLRP3 inflammasome inhibitors with inflammatory activity for colitis. J Med Chem. 2021;64(18):13633–13657.
   PubMed Web of Science ®Google Scholar
• Middleton E, Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000;52(4):673–751.
   PubMed Web of Science ®Google Scholar
• Shi JB, Chen LZ, Wang BS, Huang X, Jiao MM, Liu MM, Tang WJ, Liu XH. Novel pyrazolo[4,3- d]pyrimidine as potent and orally active Inducible Nitric Oxide Synthase (iNOS) dimerization inhibitor with efficacy in rheumatoid arthritis mouse model. J Med Chem. 2019;62(8):4013–4031.
   PubMed Web of Science ®Google Scholar
• Poulos TL, Li H. Nitric oxide synthase and structure-based inhibitor design. Nitric Oxide. 2017;63:68–77.
   PubMed Web of Science ®Google Scholar
• Serafini M, Peluso I, Raguzzini A. Flavonoids as anti-inflammatory agents. Proc Nutr Soc. 2010;69(3):273–278.
   PubMed Web of Science ®Google Scholar
• Maleki SJ, Crespo JF, Cabanillas B. Anti-inflammatory effects of flavonoids. Food Chem. 2019;299:125124.
   PubMed Web of Science ®Google Scholar
• Peng HL, Huang WC, Cheng SC, Liou CJ. Fisetin inhibits the generation of inflammatory mediators in interleukin-1β-induced human lung epithelial cells by suppressing the NF-κB and ERK1/2 pathways. Int Immunopharmacol. 2018;60:202–210.
   PubMed Web of Science ®Google Scholar
• Cheng L, Ren Y, Lin D, Peng S, Zhong B, Ma Z. The anti-inflammatory properties of citrus wilsonii Tanaka extract in LPS-induced RAW 264.7 and primary mouse bone marrow-derived dendritic cells. Molecules. 2017;22(7):1213.
   PubMed Web of Science ®Google Scholar
• Naffaa M, Makhoul BF, Tobia A, Kaplan M, Aronson D, Saliba W, Azzam ZS. Interleukin-6 at discharge predicts all-cause mortality in patients with sepsis. Am J Emerg Med. 2013;31(9):1361–1364.
   PubMed Web of Science ®Google Scholar
• Patel BV, Wilson MR, O’Dea KP, Takata M. TNF-induced death signaling triggers alveolar epithelial dysfunction in acute lung injury. J Immunol. 2013;190(8):4274–4282.
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol. 2001;1(2):135–145.
   PubMed Web of Science ®Google Scholar
• Hu N, Wang C, Dai X, Zhou M, Gong L, Yu L, Peng C, Li Y. Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway. J Ethnopharmacol. 2020;248:112361.
   PubMed Web of Science ®Google Scholar